AstraZeneca Total Liabilities 1992-2025 | AZN
AstraZeneca total liabilities from 1992 to 2025. Total liabilities can be defined as the total value of all possible claims against the corporation.
- AstraZeneca total liabilities for the quarter ending June 30, 2025 were $67.612B, a 4.43% increase year-over-year.
- AstraZeneca total liabilities for 2024 were $63.164B, a 1.95% increase from 2023.
- AstraZeneca total liabilities for 2023 were $61.953B, a 4.25% increase from 2022.
- AstraZeneca total liabilities for 2022 were $59.425B, a 10.07% decline from 2021.
| AstraZeneca Annual Total Liabilities (Millions of US $) |
|
|---|---|
| 2024 | $63,164 |
| 2023 | $61,953 |
| 2022 | $59,425 |
| 2021 | $66,076 |
| 2020 | $51,091 |
| 2019 | $46,781 |
| 2018 | $46,607 |
| 2017 | $46,712 |
| 2016 | $45,857 |
| 2015 | $41,547 |
| 2014 | $38,949 |
| 2013 | $32,646 |
| 2012 | $29,588 |
| 2011 | $29,364 |
| 2010 | $32,717 |
| 2009 | $34,099 |
| 2008 | $19,869 |
| 2007 | $33,179 |
| 2006 | $14,628 |
| 2005 | $11,243 |
| 2004 | $11,097 |
| 2003 | $10,395 |
| 2002 | $10,404 |
| 2001 | $8,163 |
| 2000 | $8,892 |
| 1999 | $8,261 |
| 1998 | $4,803 |
| 1997 | $4,672 |
| 1996 | |